Metraipolis › archive › dc_1fee84e62fc0
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107 — Europe PMC PMID:41216708
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41216708
- DOI
- 10.1002/1878-0261.70148
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:27:11.849Z
- SHA-256 of the archived text
e228cc40116f575180d5bc4e45b1b6483c059c65a427ab22ffacbbad473e127e- Stable URL of this page
https://metraipolis.com/documento/dc_1fee84e62fc0
How to cite
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107 — Europe PMC PMID:41216708 — Europe PMC (en), https://europepmc.org/article/MED/41216708 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fee84e62fc0 (Metraipolis archive dc_1fee84e62fc0, sha256 e228cc40116f575180d5bc4e45b1b6483c059c65a427ab22ffacbbad473e127e)
BibTeX
@misc{dc1fee84e62fc0,
title = {Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107 — Europe PMC PMID:41216708},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41216708},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fee84e62fc0; sha256 e228cc40116f575180d5bc4e45b1b6483c059c65a427ab22ffacbbad473e127e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41216708. Agents can read the archived copy with the MCP tool read_document.